306 related articles for article (PubMed ID: 34530705)
21. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
[TBL] [Abstract][Full Text] [Related]
22. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
[TBL] [Abstract][Full Text] [Related]
23. Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.
Sharma B; Satija G; Madan A; Garg M; Alam MM; Shaquiquzzaman M; Khanna S; Tiwari P; Parvez S; Iqubal A; Haque SE; Khan MA
Inflammation; 2023 Feb; 46(1):56-87. PubMed ID: 36006570
[TBL] [Abstract][Full Text] [Related]
24. The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.
Yap JKY; Pickard BS; Chan EWL; Gan SY
Mol Neurobiol; 2019 Nov; 56(11):7741-7753. PubMed ID: 31111399
[TBL] [Abstract][Full Text] [Related]
25. Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer's Disease Patients.
La Rosa F; Zoia CP; Bazzini C; Bolognini A; Saresella M; Conti E; Ferrarese C; Piancone F; Marventano I; Galimberti D; Fenoglio C; Scarpini E; Clerici M
Cells; 2022 Jul; 11(14):. PubMed ID: 35883623
[TBL] [Abstract][Full Text] [Related]
26. NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration.
Sita G; Graziosi A; Hrelia P; Morroni F
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209586
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.
Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA
Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153
[TBL] [Abstract][Full Text] [Related]
28. Inflammasomes as therapeutic targets for Alzheimer's disease.
White CS; Lawrence CB; Brough D; Rivers-Auty J
Brain Pathol; 2017 Mar; 27(2):223-234. PubMed ID: 28009077
[TBL] [Abstract][Full Text] [Related]
29. AGE-TXNIP axis drives inflammation in Alzheimer's by targeting Aβ to mitochondria in microglia.
Sbai O; Djelloul M; Auletta A; Ieraci A; Vascotto C; Perrone L
Cell Death Dis; 2022 Apr; 13(4):302. PubMed ID: 35379773
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease.
Severini C; Barbato C; Di Certo MG; Gabanella F; Petrella C; Di Stadio A; de Vincentiis M; Polimeni A; Ralli M; Greco A
Curr Neuropharmacol; 2021; 19(4):498-512. PubMed ID: 32564756
[TBL] [Abstract][Full Text] [Related]
31. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
Liu Y; Dai Y; Li Q; Chen C; Chen H; Song Y; Hua F; Zhang Z
Neurosci Lett; 2020 Sep; 736():135279. PubMed ID: 32726591
[TBL] [Abstract][Full Text] [Related]
32. The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice.
Li JM; Hu T; Zhou XN; Zhang T; Guo JH; Wang MY; Wu YL; Su WJ; Jiang CL
J Neuroinflammation; 2023 May; 20(1):112. PubMed ID: 37165444
[TBL] [Abstract][Full Text] [Related]
33. Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement.
Chiu YJ; Lin CH; Lee MC; Hsieh-Li HM; Chen CM; Wu YR; Chang KH; Lee-Chen GJ
Aging (Albany NY); 2021 Jun; 13(11):15620-15637. PubMed ID: 34106880
[TBL] [Abstract][Full Text] [Related]
34. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
[TBL] [Abstract][Full Text] [Related]
35. Structures and functions of the inflammasome engine.
Wang L; Sharif H; Vora SM; Zheng Y; Wu H
J Allergy Clin Immunol; 2021 Jun; 147(6):2021-2029. PubMed ID: 34092352
[TBL] [Abstract][Full Text] [Related]
36. Involvement of NLRC4 inflammasome through caspase-1 and IL-1β augments neuroinflammation and contributes to memory impairment in an experimental model of Alzheimer's like disease.
Saadi M; Karkhah A; Pourabdolhossein F; Ataie A; Monif M; Nouri HR
Brain Res Bull; 2020 Jan; 154():81-90. PubMed ID: 31715312
[TBL] [Abstract][Full Text] [Related]
37. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
Qiu WQ; Pan R; Tang Y; Zhou XG; Wu JM; Yu L; Law BY; Ai W; Yu CL; Qin DL; Wu AG
Biomed Pharmacother; 2020 Oct; 130():110575. PubMed ID: 32768883
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
39. Genes associated with amyloid-beta-induced inflammasome-mediated neuronal death identified using functional gene trap mutagenesis approach.
Yap JKY; Pickard BS; Gan SY; Chan EWL
Int J Biochem Cell Biol; 2021 Jul; 136():106014. PubMed ID: 34022435
[TBL] [Abstract][Full Text] [Related]
40. Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease.
Bai H; Zhang Q
Front Immunol; 2021; 12():701282. PubMed ID: 34381452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
